NCT02005718

Brief Summary

Vitamin D deficiency is common in CKD and assciated with CV complications. Endothelial dysfucntion is common in CKD and is a harbinger of atherosclerosis. The study investigated the impact of Vitamin D on endothelial fucntion and blood biomarkers in CKD.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Jun 2010

Typical duration for phase_3

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2010

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2013

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

December 3, 2013

Completed
6 days until next milestone

First Posted

Study publicly available on registry

December 9, 2013

Completed
Last Updated

December 9, 2013

Status Verified

December 1, 2013

Enrollment Period

3 years

First QC Date

December 3, 2013

Last Update Submit

December 3, 2013

Conditions

Outcome Measures

Primary Outcomes (1)

  • Flow mediated dilation

    16 weeks

Secondary Outcomes (2)

  • CD28 null cell frequency

    16 weeks

  • Blood biomarkers of endothelial function and inflammation

    16 weeks

Study Arms (1)

Vitamin D

EXPERIMENTAL

Cholecalciferol 300,000 twice

Drug: Cholecalciferol

Interventions

Vitamin D

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • CKD 3-4 Age 18-80

You may not qualify if:

  • Recent MI, CVA, malignancy active infection active inflammation High calcium already on Viatmin D therapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Chitalia N, Ismail T, Tooth L, Boa F, Hampson G, Goldsmith D, Kaski JC, Banerjee D. Impact of vitamin D supplementation on arterial vasomotion, stiffness and endothelial biomarkers in chronic kidney disease patients. PLoS One. 2014 Mar 19;9(3):e91363. doi: 10.1371/journal.pone.0091363. eCollection 2014.

MeSH Terms

Interventions

Cholecalciferol

Intervention Hierarchy (Ancestors)

CholestenesCholestanesSteroidsFused-Ring CompoundsPolycyclic CompoundsSterolsVitamin DSecosteroidsMembrane LipidsLipids

Study Officials

  • Debasish Banerjee

    St Georges

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 3, 2013

First Posted

December 9, 2013

Study Start

June 1, 2010

Primary Completion

June 1, 2013

Study Completion

June 1, 2013

Last Updated

December 9, 2013

Record last verified: 2013-12